Adam Simpson

Mr. Simpson brings significant operational and emerging company experience to Cypher Genomics. Prior to his appointment as Cypher’s president and COO, Simpson served as an executive advisor to life science investors and companies including Cypher Genomics.

Before that, Simpson was co-founder and chief business officer of Meritage Pharma from company creation through an option agreement with ViroPharma for its sale, was the general counsel at Verus Pharmaceuticals where he led its sale to AstraZeneca and Shionogi, and previously was an attorney at Latham and Watkins. He holds a B.S. in biochemistry and cell biology from the University of California, San Diego and received a J.D. from the University of Minnesota Law School.